Covid 19 Generic Drug
- All
- News
'Covid 19 Generic Drug' - 2 News Result(s)
-
Cipla Set To Undercut Rivals With Generic Remdesivir: Report
Sources said the first batch of 10,000 vials had been printed with a price of Rs 4,000, Rs 800 below the cheapest option, launched by European competitor Mylan this week.
-
Cipla Gets Regulatory Nod To Make Gilead's COVID-19 Drug, Shares Hit Record High
Cipla shares surged over 9% after it got an approval from DCGI to manufacture and market generic COVID-19 drug Remdesivir.
'Covid 19 Generic Drug' - 2 News Result(s)
-
Cipla Set To Undercut Rivals With Generic Remdesivir: Report
Sources said the first batch of 10,000 vials had been printed with a price of Rs 4,000, Rs 800 below the cheapest option, launched by European competitor Mylan this week.
-
Cipla Gets Regulatory Nod To Make Gilead's COVID-19 Drug, Shares Hit Record High
Cipla shares surged over 9% after it got an approval from DCGI to manufacture and market generic COVID-19 drug Remdesivir.
